Literature DB >> 32266657

Heparan Sulfate in the Tumor Microenvironment.

Barbara Bartolini1, Elena Caravà1, Ilaria Caon1, Arianna Parnigoni1, Paola Moretto1, Alberto Passi1, Davide Vigetti1, Manuela Viola2, Evgenia Karousou3.   

Abstract

The biology of tumor cells strictly depends on their microenvironment architecture and composition, which controls the availability of growth factors and signaling molecules. Thus, the network of glycosaminoglycans, proteoglycans, and proteins known as extracellular matrix (ECM) that surrounds the cells plays a central role in the regulation of tumor fate. Heparan sulfate (HS) and heparan sulfate proteoglycans (HSPGs) are highly versatile ECM components that bind and regulate the activity of growth factors, cell membrane receptors, and other ECM molecules. These HS binding partners modulate cell adhesion, motility, and proliferation that are processes altered during tumor progression. Modification in the expression and activity of HS, HSPGs, and the respective metabolic enzymes results unavoidably in alteration of tumor cell microenvironment. In this light, the targeting of HS structure and metabolism is potentially a new tool in the treatment of different cancer types.

Entities:  

Keywords:  Adhesion; Angiogenesis; Cancer; Cell growth; Extracellular matrix; Glycosaminoglycan; Growth factor; Heparan sulfate; Heparanase; Inflammation; Invasion; Metastasis; Proteoglycan; Tumor; UDP-sugars

Mesh:

Substances:

Year:  2020        PMID: 32266657     DOI: 10.1007/978-3-030-40146-7_7

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  8 in total

1.  Co-Variation of Serum Osteoprotegerin and Pigment-Epithelial Derived Factor as Biomarker of Pancreatic Cancer.

Authors:  M Edderkaoui; C Chheda; A Lim; S J Pandol; R Murali
Journal:  Austin J Gastroenterol       Date:  2022-01-19

Review 2.  What Are the Potential Roles of Nuclear Perlecan and Other Heparan Sulphate Proteoglycans in the Normal and Malignant Phenotype.

Authors:  Anthony J Hayes; James Melrose
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

3.  Chemotherapy-Induced Degradation of Glycosylated Components of the Brain Extracellular Matrix Promotes Glioblastoma Relapse Development in an Animal Model.

Authors:  Alexandra Y Tsidulko; Oleg B Shevelev; Anna S Khotskina; Mariia A Kolpakova; Anastasia V Suhovskih; Galina M Kazanskaya; Alexander M Volkov; Svetlana V Aidagulova; Evgenii L Zavyalov; Elvira V Grigorieva
Journal:  Front Oncol       Date:  2021-07-19       Impact factor: 6.244

Review 4.  CD44 Glycosylation as a Therapeutic Target in Oncology.

Authors:  Chengcheng Liao; Qian Wang; Jiaxing An; Jie Chen; Xiaolan Li; Qian Long; Linlin Xiao; Xiaoyan Guan; Jianguo Liu
Journal:  Front Oncol       Date:  2022-07-21       Impact factor: 5.738

Review 5.  Cell Energy Metabolism and Hyaluronan Synthesis.

Authors:  Ilaria Caon; Arianna Parnigoni; Manuela Viola; Evgenia Karousou; Alberto Passi; Davide Vigetti
Journal:  J Histochem Cytochem       Date:  2020-07-06       Impact factor: 2.479

6.  HA and HS Changes in Endothelial Inflammatory Activation.

Authors:  Elena Caravà; Paola Moretto; Ilaria Caon; Arianna Parnigoni; Alberto Passi; Evgenia Karousou; Davide Vigetti; Jessica Canino; Ilaria Canobbio; Manuela Viola
Journal:  Biomolecules       Date:  2021-05-29

Review 7.  Heparan Sulfate Proteoglycan Signaling in Tumor Microenvironment.

Authors:  Valeria De Pasquale; Luigi Michele Pavone
Journal:  Int J Mol Sci       Date:  2020-09-09       Impact factor: 5.923

Review 8.  The Role of IGF/IGF-IR-Signaling and Extracellular Matrix Effectors in Bone Sarcoma Pathogenesis.

Authors:  George N Tzanakakis; Eirini-Maria Giatagana; Aikaterini Berdiaki; Ioanna Spyridaki; Kyoko Hida; Monica Neagu; Aristidis M Tsatsakis; Dragana Nikitovic
Journal:  Cancers (Basel)       Date:  2021-05-19       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.